These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 12451697)

  • 1. [Role of cholecystokinin receptor in methamphetamine-induced reverse tolerance].
    Shimazoe T; Fukumoto T; Shuto T; Watanabe S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2002 Oct; 22(5):207. PubMed ID: 12451697
    [No Abstract]   [Full Text] [Related]  

  • 2. Peripheral cholecystokinin A and cholecystokinin B receptors mediate stimulation of gastric pepsinogen and acid secretion following intracerebroventricular injection of cholecystokinin-8-sulphate.
    Blandizzi C; Lazzeri G; Carignani D; Colucci R; Baschiera F; Tognetti M; Placanica G; Del Tacca M
    Ital J Gastroenterol Hepatol; 1999; 31(6):440-8. PubMed ID: 10575559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholecystokinin receptor mechanism(s) and morphine tolerance in mice.
    Zarrindast MR; Nikfar S; Rezayat M
    Pharmacol Toxicol; 1999 Jan; 84(1):46-50. PubMed ID: 9974190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the cholecystokinin-B receptor antagonist L-365,260 on lactate-induced panic attacks in panic disorder patients.
    van Megen HJ; Westenberg HG; den Boer JA
    Biol Psychiatry; 1996 Oct; 40(8):804-6. PubMed ID: 8894076
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of cholecystokinin type B receptors in ultrasound induced behavior in rats.
    Voits M; Beckett SR; Marsden CA; Fink H
    Peptides; 1999; 20(3):383-6. PubMed ID: 10447098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposite modulation of apomorphine- or amphetamine-induced stereotypy by antagonists of CCK receptors.
    Tieppo CA; Ferreira FS; Sassatani AS; Felicio LF; Nasello AG
    Eur J Pharmacol; 2000 Jan; 387(2):189-96. PubMed ID: 10650159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonistic effect of CCK-8 on morphine-inhibited electrical and contractile activities of rat jejunum in vitro.
    Xu MY; Yang DX; Wang SZ; Jin HB; Zou XH; Yang XP; Han JS
    Sheng Li Xue Bao; 1998 Aug; 50(4):469-73. PubMed ID: 11324560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of CCK1 and CCK2 receptor blockade on amphetamine-stimulated exploratory behavior and sensitization to amphetamine.
    Alttoa A; Harro J
    Eur Neuropsychopharmacol; 2004 Aug; 14(4):324-31. PubMed ID: 15163443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of cholecystokinin receptor in the inhibition of gastrointestinal motility by oxytocin in ovariectomized rats.
    Wu CL; Doong ML; Wang PS
    Eur J Pharmacol; 2008 Feb; 580(3):407-15. PubMed ID: 18078924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A locus and mechanism of action for associative morphine tolerance.
    Mitchell JM; Basbaum AI; Fields HL
    Nat Neurosci; 2000 Jan; 3(1):47-53. PubMed ID: 10607394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of acetylcholine release by cholecystokinin in striatum: receptor specificity; role of dopaminergic neuronal activity.
    Petkova-Kirova P; Giovannini MG; Kalfin R; Rakovska A
    Brain Res Bull; 2012 Dec; 89(5-6):177-84. PubMed ID: 22981453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible role of CCKB-receptors in anxiety: an "in vivo" study.
    Tessari M; Maraia G; Reggiani A
    Pharmacol Res; 1992; 25 Suppl 1():55-6. PubMed ID: 1508810
    [No Abstract]   [Full Text] [Related]  

  • 13. Analysis of the behaviour of selected CCKB/gastrin receptor antagonists in radioligand binding assays performed in mouse and rat cerebral cortex.
    Harper EA; Griffin EP; Shankley NP; Black JW
    Br J Pharmacol; 1999 Mar; 126(6):1496-503. PubMed ID: 10217545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of motor behaviour by NMDA- and cholecystokinin-antagonism.
    Broberger C; Blacker D; Giménez-Llort L; Herrera-Marschitz M; Ogren SO; Hökfelt T
    Amino Acids; 1998; 14(1-3):25-31. PubMed ID: 9871437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of tolerance to the antinociceptive effects of systemic morphine by a selective cholecystokinin-B receptor antagonist in a rat model of peripheral neuropathy.
    Idänpään-Heikkilä JJ; Guilbaud G; Kayser V
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1366-72. PubMed ID: 9316848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological properties of the benzodiazepine amidine derivative L-740,093, a cholecystokinin-B/gastrin receptor antagonist with high affinity in vitro and high potency in vivo.
    Patel S; Smith AJ; Chapman KL; Fletcher AE; Kemp JA; Marshall GR; Hargreaves RJ; Ryecroft W; Iversen LL; Iversen SD
    Mol Pharmacol; 1994 Nov; 46(5):943-8. PubMed ID: 7969084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient agonist-induced regulation of the cholecystokinin-A and cholecystokinin-B receptor mRNA levels in rat pancreatic acinar AR42J cells.
    Günther R; Carstens OC; Schmidt WE; Fölsch UR
    Pancreatology; 2003; 3(1):47-54. PubMed ID: 12649564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholecystokinin antianalgesia: safety cues abolish morphine analgesia.
    Wiertelak EP; Maier SF; Watkins LR
    Science; 1992 May; 256(5058):830-3. PubMed ID: 1589765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal deprivation increases behavioural reactivity to stressful situations in adulthood: suppression by the CCK2 antagonist L365,260.
    Vazquez V; Farley S; Giros B; Daugé V
    Psychopharmacology (Berl); 2005 Oct; 181(4):706-13. PubMed ID: 16032413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antagonistic effect of cholecystokinin octapeptide (CCK-8) on opioid effects in cardiovascular activities was mediated by CCK-B receptor.
    Mei L; Han JS
    Sci China B; 1993 Jul; 36(7):817-23. PubMed ID: 8216742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.